Related Experiment Video
Updated: May 12, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout
Huiqiong Zeng1, Zebo Cai1, Junda Lai2
1Traditional Chinese Medicine Department of Rheumatism, Women & Children Health Institute Futian Shenzhen, Guangdong, China.
Sodium-glucose transporter 2 inhibitors (SGLT2i) show promise in preventing gout. This study confirms SGLT2i reduce gout risk by influencing immune cells, particularly dendritic cells, offering new prevention strategies.
Area of Science:
- Immunology
- Pharmacology
- Genetics
Background:
- Sodium-glucose transporter 2 inhibitors (SGLT2i) are known to lower uric acid levels.
- The direct impact of SGLT2i on gout prevention is still debated.
- Immune-mediated pathways may link SGLT2i use to gout risk.
Purpose of the Study:
- To investigate the causal relationship between SGLT2i and gout risk.
- To explore the immune-mediated mechanisms underlying this association.
- To identify specific immune cell phenotypes involved in SGLT2i's effect on gout.
Main Methods:
- Utilized bidirectional two-sample Mendelian randomization (MR) analysis.
- Employed mediation analysis with genetic instruments for SGLT2i, gout, and 731 immune cell phenotypes.
- Assessed pleiotropy and heterogeneity to ensure result validity.
Main Results:
- Confirmed a significant urate-lowering effect of SGLT2i, reducing gout risk by 2.6% (OR: 0.9738).
- Identified 35 immune cell phenotypes influencing gout development.
- Highlighted CD86 on myeloid dendritic cells (DCs) as a key mediator (12.8% mediation effect).
Conclusions:
- Established SGLT2i as protective against gout through immune modulation.
- Demonstrated a significant indirect effect of SGLT2i on gout risk via dendritic cell pathways.
- Provided mechanistic insights for developing targeted gout prevention strategies.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
14:57Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Secondary Active Transport
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucose Absorption Into the Small Intestine